Seasonal variation in platelet [3H]paroxetine binding in healthy volunteers. Relationship to climate variables

Neuropsychopharmacology

Volumn 15, Issue 2, 1996, Pages 187-198

  D'Hondt, Peter ^a   Maes, Michael ^a,b,c   Leysen, Josée E ^d   Gommeren, Walter ^d   Heylen, Lieven ^d   DeMeyer, Frans ^e   Scharpe, Simon ^f   Peeters, Dirk ^a   Desnyder, Roger ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Stuivenberg General Hospital   (Belgium)

^d JANSSEN RESEARCH FOUNDATION   (Belgium)

^e ROYAL METEOROLOGICAL INSTITUTE OF BELGIUM   (Belgium)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Chronobiology; Depression; Paroxetine binding sites; Platelets; Seasonality; Serotonin

Indexed keywords

PAROXETINE;

ADULT; ARTICLE; ATMOSPHERIC PRESSURE; BINDING AFFINITY; BLOOD SAMPLING; CHRONOPHARMACOLOGY; CIRCANNUAL RHYTHM; CLINICAL TRIAL; DRUG BINDING; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HUMIDITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEASONAL VARIATION; TEMPERATURE SENSITIVITY; THROMBOCYTE ADHESION;

EID: 0030222244     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00183-E     Document Type: Article

References (60)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, revised. Washington, DC, American Psychiatric Association
2. Arora RC, Kregel L, Meltzer HY (1984): Seasonal variation of serotonin uptake in normal controls and depressed patients. Biol Psychiatry 19:795-804
3. Arora RC, Meltzer HY (1988): Seasonal variation of imipramine binding in the blood platelets of normal controls and depressed patients. Biol Psychiatry 23:217-226
4. Asarch KB, Shih JC, Kubesar A (1980): Decreased 3H-imipramine binding in depressed males and females. Commun Psychopharmacol 4:425-432
5. Brewerton TD (1989): Seasonal variation of serotonin function in humans: Research and clinical implications. Ann Clin Psychiatry 1:153-164
6. Brewerton TD, Berrettini W, Nurnberger J, Linnoila M (1988): An analysis of seasonal fluctuations of CSF monoamines and neuropeptides in normal controls: Findings with 5-HIAA and HVA. Psychiatr Res 23:257-265
7. Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980): Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209:303-305
8. Bruguerolle B (1992): Chronopharmacology. In Biologic Rhythms in Clinical and Laboratory Medicine. Berlin, Springer-Verlag, pp 114-137
9. Buus-Lassen J, Lund J, Søndergaard I (1980): Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and clomipramine. Psychopharmacology 68:229
10. Carlsson A, Svennerholm L, Winblad B (1979): Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl 75-85
11. 3H]5-HT uptake: Effect of administration of various antidepressant treatments. Neuropharmacology 32:737-743
12. 3H]paroxetine. Neuroscience 27:473-496
13. 3H-imipramine binding in normal controls. Biol Psychiatry 26:489-495
14. De Meyer F, Vogelaere P (1990): Spectral resolution of cardiocirculatory variations in men measured by autorhythmometry over 2 years. Int J Biometeorol 34:105-121
15. D'Hondt P, Maes M, Leysen J, Gommeren W, Scharpé S, Cosyns P (1994): Binding of 3[H]paroxetine to platelets of depressed patients: Seasonal differences and effects of diagnostic classification. J Affective Dis 32:27-35
16. Egrise D, Desmedt D, Schoutens A, Mendlewitz J (1983): Circannual variations in the density of titriated imipramine binding sites on blood platelets in man. Neuropsychobiology 10:101-102
17. 3H-imipramine binding in normal and depressed subjects. Biol Psychiatry 21:283-292
18. Fichtner CG, Arora RC, O'Connor FL, Crayton JW (1994): Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: Preliminary observations on a possible predictor of clinical treatment response. Life Sci 54:39-44
19. Fraser CG (1994): Data on biological variation: Essential pre-requisites for introducing new procedures (editorial). Clin Chem 40:1671-1673
20. 3H-imipramine binding in humans. Biol Psychiatry 21:876-882
21. Galzin AM, Poirier M-F, Loo H, Sechter D, Zarifian E, Langer SZ (1988): [3H]Paroxetine binding from healthy volunteers and depressed patients. Br J Pharmacol 93:12P
22. Habert E, Graham D, Tahraoui L, Claustre Y, Langer S (1985): Characterization of [3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol 118:107-114
23. Heron DS, Shinitzky M, Hershkowitz M, Samuel D (1980): Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci USA 77:7463-7467
24. Hrdina PD, Lapierre YD, Horn ER, Bakish D (1985): Platelet 3H-imipramine binding: A possible predictor of response to antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 9:619-623
25. Kanoff PD, Coccaro EF, Johns CA, Siever L, Davis KL (1987): Platelet 3H-imipramine binding in psychiatric disorders. Biol Psychiatry 22:278-286
26. Klompenhouwer JL, Fekkes D, van Hulst AM, Moleman P, Pepplinkhuizen L, Mulder PGH (1990): Seasonal variations in binding of 3H-paroxetine to blood platelets in healthy volunteers: Indications for a gender difference. Biol Psychiatry 28:509-517
27. Laduron PM, Robbyns M, Schotte A (1982): 3H-Desipramine and 3H-imipramine are not associated with noradrenaline and serotonin uptake. Eur J Pharmacol 78:491-493
28. Laruelle M, Vanisberg MA, Maloteaux JM (1988): Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry 24:299-309
29. Lawrence KM, De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW (1990): Brain 5-HT uptake sites, labeled with [3H]paroxetine, in antidepressant-free suicides. Brain Res 526:17-22
30. Lesch KP, Wolozin BL, Murphy DL, Reiderer P (1993): Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem 60:2319-2322
31. Lévi F, Canon C, Touitou Y, Reinberg A, Mathé G (1988): Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects. J Clin Invest 81:407-413
32. 2 receptor binding sites: binding properties, brain distribution, and functional role. Mol Pharmacol 21:301
33. Leysen JE, Gommeren W, De Clerck F (183): Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin. Eur J Pharmacol 88:125-130
34. Maes M, De Meyer F, Peeters D, Meltzer HY, Schotte C, Scharpe S, Cosyns P (1993a): Seasonality and meteotropism in psychiatric psychopathology: The periodicities in and biometerological relationships with the number of patients admitted to an acute psychiatric ward. Int J Biometeorol 37:78-82
35. Maes M, Cosyns P, Meltzer HY, De Meyer F, Peeters D (1993b): Significant seasonality in violent suicide occurrence but not in nonviolent suicide or homicide occurrence. Am J Psychiatry 150:1380-1385
36. Maes M, Delanghe J, Meltzer HY, Scharpé S, D'Hondt P, Cosyns P (1994a): Lower degree of esterification of serum cholesterol in depression: Relevance for depression and suicide research. Acta Psychiatr Scand 90:252-258
37. Maes M, Scharpé S, De Meester I, Goossens P, Wauters A, Neels H, Verkerk R, De Meyer F, D'Hondt P, Peeters D, Schotte C, Cosyns P (1994b): Components of biological variation in plasma prolyl endopeptidase and dipeptidyl peptidase activity in healthy man. Clin Chem 40: 1686-1691
38. Maes M, Meltzer HYM, (1995): The serotonin hypothesis of major depression. In Bloom FE, Kupfer DJ (eds), Psycho pharmacology, the Fourth Generation of Progress. New York, Raven Press, 933-944
39. Maes M, Cosyns P, DeMeyer F, Thompson P, Peeters D (1995a): Synchronized annual rhythms in violent suicide, ambient temperature, and sunlight duration. Acta Psychiatr Scand 90:391-396
40. Maes M, Scharpé S, Verkerk R, D'Hondt P, Peeters D, Cosyns P, Thompson P, De Meyer F, Wauters A, Neels H (1995b): Components of biological variation, including seasonality in plasma L-tryptophan and competing amino-acids in man: Relationships to serum total protein, climatic variables, and violent suicide occurrence. Arch Gen Psychiatry 52:937-946
41. Mellerup ET, Plenge P (1986): High affinity binding of [3H]paroxetine and [3H]imipramine to rat neuronal membranes. Psychopharmacology 89:436-439
42. Mellerup ET, Plenge P, Engelstoft M (1983): High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes. Eur J Pharmacol 96:303-309
43. Mellerup ET, Plenge P, Nielsen M (1985): Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes. Eur J Pharmacol 106:411-413
44. Meltzer HY, Arora RC (1991): Platelet serotonin studies in affective disorders: evidence for a serotonergic abnormality. In Sandler M, Coppen A, Harnett S (eds), 5-Hydroxytryptamine in Psychiatry: A Spectrum of Ideas. New York, Oxford University Press, pp 50-89
45. 3H]paroxetine than did the comparison subjects. Am J Psychiatry 151:1623-1625
46. Oestricher EG, Pinto GF (1987): A microcomputer program for fitting enzyme inhibition rate equations. Comput Biol Med 17:53-68
47. Ostrom CW (1988): The Time Series Analysis: Regression Techniques. In Sullivan JL, Niemi RG (eds), Quantitative Applications in the Social Sciences. London, Sage Publications
48. Robinson D, Hinohara S, Bevan EA, Takahashi T (1993): Seasonal variation in serum cholesterol levels in health screening populations from the UK and Japan. J Med Syst 17:207-211
49. Sarrias MJ, Artigas F, Martinez E, Gelpi E (1989): Seasonal changes of plasma serotonin and related parameters: correlations with environmental measures. Biol Psychiatry 26:695-706
50. Sneddon JM (1969): Sodium-dependent accumulation of 5-hydroxytryptamine by rat blood platelets. Br J Pharmacol 37:680-688
51. Sneddon JM (1973): Blood platelets as a model for monoamine-containing neurons. Prog Neurobiol 1:151-198
52. Spitzer RL, Williams JBW, Gibbon MSW, First MB (1990): Structured Clinical Interview According to DSM-III-R. American Psychiatric Press, Inc.
53. Stahl SM (1977): The human platelet: A diagnostic and research tool for the study of biogenic amines in psychiatry and neurologic disorders. Arch Gen Psychiatry 34:509-516
54. Suranyi-Cadotte BE, Wood PL, Schwartz G, Nair NPV (1983): Altered platelet 3H-imipramine binding in schizoaffective and depressive disorders. Biol Psychiatry 18:923-927
55. Swade C, Coppen A (1980): Seasonal variations in biochemical factors related to depressive illness. J Affective Disord 2:249-255
56. Szadoczky E, Falus A, Arato M, Nemeth A, Teszeri G, Kovacs E-M (1989): Phototherapy increases platelet 3[H]-imipramine binding in patients with winter depression. J Affective Disord 16:121-125
57. 3H-imipramine binding. Psychiatr Res 16:141-146
58. Touitou Y, Haus E (1992): Biologic Rhythms in Clinical and Laboratory Medicine, Berlin, Springer-Verlag, pp 1-730
59. Whitaker PM, Warsh JJ, Stancer HC, Persad E, Vint CK (1984): Seasonal variation in platelet 3H-imipramine binding: Comparable values in control and depressed population. Psychiatr Res 11:127-131
60. Wirz-Justice A, Richter R (1979): Seasonality in biochemical determinations: A source of variance and a clue to the temporal incidence of affective illness. Psychiatr Res 1:53-60